首页 › 基金 › SUPERSTRING CAPITAL MANAGEMENT LP › TARA
SUPERSTRING CAPITAL MANAGEMENT LP 对 TARA 的持仓历史
PROTARA THERAPEUTICS INC · 医疗保健
SUPERSTRING CAPITAL MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 TARA(PROTARA THERAPEUTICS INC)121,457 股,市值约 US$464K,约占其申报组合的 0.29%,在其申报持仓中市值排名第 28 位。 SUPERSTRING CAPITAL MANAGEMENT LP 最近 7 个申报季度中有 7 个季度披露了 TARA 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
SUPERSTRING CAPITAL MANAGEMENT LP 对 TARA 的持仓演变
SUPERSTRING CAPITAL MANAGEMENT LP 于 Q4 2024 首次披露 TARA 持仓:360,000 股(约 US$1.9M)。 该持仓在 Q4 2025 达到峰值 360,000 股,市值约 US$1.9M。 在 7 次申报中,SUPERSTRING CAPITAL MANAGEMENT LP 0 次增持、1 次减持、5 次保持不变。 最近一期申报(Q2 2026)显示持股 121,457 股、市值约 US$464K。 持仓曾出现大幅变动:Q1 2026 减持约 66% (随后一个季度股价下跌 27%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 360.00K | $1.90M | 新进 |
| Q1 2025 | 360.00K | $1.53M | 持有 |
| Q2 2025 | 360.00K | $1.09M | 持有 |
| Q3 2025 | 360.00K | $1.57M | 持有 |
| Q4 2025 | 360.00K | $1.92M | 持有 |
| Q1 2026 | 121.46K | $632.79K | 减持 |
| Q2 2026 | 121.46K | $463.97K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TARA 与 13F 数据
TARA(PROTARA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 TARA,申报仓位最大的包括:Velan Capital Investment Management LP (US$10.9M), Sio Capital Management, LLC (US$7.3M), ACORN CAPITAL ADVISORS, LLC (US$6.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TARA 的基金
- Velan Capital Investment Management LP 2.84M 股 · $10.87M · Q2 2026
- Sio Capital Management, LLC 1.92M 股 · $7.34M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.75M 股 · $6.69M · Q2 2026
- 5AM Venture Management, LLC 1.37M 股 · $5.23M · Q2 2026
- Catalio Capital Management, LP 520.15K 股 · $1.99M · Q2 2026
- Verdad Advisers, LP 312.25K 股 · $1.19M · Q2 2026
更多关于 SUPERSTRING CAPITAL MANAGEMENT LP
常见问题
How long has SUPERSTRING CAPITAL MANAGEMENT LP held TARA?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed TARA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in TARA?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 121.46K shares of TARA (PROTARA THERAPEUTICS INC), valued at $463.97K, representing 0.29% of its reported portfolio and ranking #28.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling TARA?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP held unchanged its position in TARA. The position peaked in Q4 2025 at 360.00K shares.
Which other funds hold TARA?
Other major institutional holders of TARA include Velan Capital Investment Management LP, Sio Capital Management, LLC, ACORN CAPITAL ADVISORS, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.